Comments
Loading...
Latest PharmaCyte Biotech Stock News | NASDAQ:PMCB | Benzinga
Get the latest news on PharmaCyte Biotech stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on PharmaCyte Biotech performance
Categories: All
Tuesday, May 21, 2024
Thursday, November 23, 2023
Wednesday, November 15, 2023
Tuesday, October 31, 2023
Monday, October 02, 2023
Tuesday, September 26, 2023
Wednesday, June 14, 2023
Thursday, May 11, 2023
Thursday, February 02, 2023
Friday, October 07, 2022
Thursday, July 28, 2022
Tuesday, July 19, 2022
Monday, July 11, 2022
Tuesday, July 05, 2022
Wednesday, June 15, 2022
Thursday, June 09, 2022
Wednesday, June 08, 2022
Thursday, June 02, 2022
Monday, May 23, 2022
Wednesday, May 11, 2022
Thursday, April 28, 2022
Friday, April 22, 2022
Tuesday, April 19, 2022
Wednesday, April 13, 2022
Tuesday, March 22, 2022
Wednesday, March 16, 2022
Tuesday, February 22, 2022
Monday, February 14, 2022
- PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
- PharmaCyte Biotech Says After Submission Of IND, FDA Requested Additional Studies And Information As Prerequisite Of PharmaCyte's IND; Co. Says A Number Of Additional Studies And Assays Have Already Been Completed